Travere Therapeutics
TVTX
TVTX
119 hedge funds and large institutions have $908M invested in Travere Therapeutics in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
19
Increased
42
Reduced
38
Closed
17
Calls
$8.85M
Puts
$1.21M
Net Calls
+$7.65M
Net Calls Change
-$6.95M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$15.4M |
| 2 |
PA
Perceptive Advisors
New York
|
+$12.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$11M |
| 4 |
Millennium Management
New York
|
+$8.47M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$7.03M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$18.6M |
| 2 |
IPLA
Ice Pond Lane Advisers
New York
|
-$10.9M |
| 3 |
BC
Broadfin Capital
New York
|
-$10.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.37M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.03M |
